ELV vs LIVN: fair value comparison
Elevance Health, Inc. and LivaNova PLC · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, ELV currently sits closer to the top of our discount ranking.
| ELV | LIVN | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $394.43 | $82.46 |
| 12-month range | $294.07–$402.66 | $50.61–$82.48 |
| Sector rank | #71 of 113 Healthcare | #76 of 113 Healthcare |
| Quality grade | D | D |
| Leverage | Moderate | Low |
| Margin trend | Stable | — |
| Revenue growth | Modest | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | Undervalued | — |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: ELV fair value analysis · LIVN fair value analysis